Safety of human therapeutic morphine vaccine employing Lohmann specific pathogen free eggs

A Farhangi1, A Akbarzadeh, M R Mehrabi

  • 1Department of Pilot Biotechnology, Pasteur Institute of Iran, Iran.

Insights

This study assessed the safety of a morphine vaccine using specific pathogen-free eggs. Results indicate the vaccine is safe, showing no adverse effects on embryo development or weight.

Area of Science:

  • Veterinary Virology
  • Vaccine Safety Testing
  • Embryology

Background:

  • Vaccine safety is critical and standard tests involve inoculating specific pathogen-free (SPF) eggs.
  • Lohmann SPF eggs are a recognized model for vaccine safety evaluation.

Purpose of the Study:

  • To evaluate the safety of a morphine vaccine.
  • To determine if morphine vaccine affects embryo development and egg parameters.

Main Methods:

  • Utilized 30 Lohmann SPF eggs, divided into test (morphine vaccine) and control (saline) groups.
  • Monitored egg and subsequent chicken weights, embryo safety, and overall development over three weeks.
  • Controlled variables included egg weight, embryo viability, vaccine concentration, saline, and incubator temperature.

Main Results:

  • Eggs in both control and test groups exhibited healthy growth and development.
  • No significant differences in weight changes were observed between the morphine-vaccinated and control groups.
  • All embryos demonstrated normal evolution and survival, with no adverse reactions noted post-vaccination.

Conclusions:

  • The morphine vaccine is deemed safe for use, as demonstrated by its lack of adverse effects in SPF embryo eggs.
  • The Lohmann SPF egg model effectively confirmed the safety profile of the therapeutic human morphine vaccine.